Sensus squeaks out with $11M IPO for low-energy x-ray treatment

Sensus Healthcare ($SRTSU) raised $11 million by selling two million units at $5.50. That was after the company had reduced its proposed price of $6.25. This is the third med tech IPO in the U.S. this week; Clearside Biomedical ($CLSD) similarly had to reduce its price ahead of the IPO but traded up in its first day. Sensus was also gaining ground in early trading--up 7% in early trading to $5.90. The company offers superficial radiation treatment devices for non-melanoma skin cancer and keloids with installations in more than 220 locations. More